NCT00097032View on ClinicalTrials.gov

Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

May 31, 2005

Conditions
Bipolar Disorder
Interventions
DRUG

risperidone; quetiapine

All Listed Sponsors
collaborator

Janssen, LP

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00097032 - Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients | Biotech Hunter | Biotech Hunter